From: Immunoregulatory effects of AFP domains on monocyte-derived dendritic cell function
 |  | Surface Marker Expression (%) | ||||
---|---|---|---|---|---|---|
 |  | CD14+ | HLA-DRhigh | CD80+ | CD40+ | CD83+ |
 |  |  | /CD11chigh | /CD86high |  |  |
 | Monocytes* | 91.03 ± 0.75 | 42.70 ± 2.04 | 0.03 ± 0.03 | 22.83 ± 9.92 | 2.20 ± 0.70 |
Non Treated | imMDDC | 5.80 ± 2.91 | 67.47 ± 3.94 | 1.33 ± 0.10 | 52.47 ± 14.98 | 15.83 ± 6.70 |
 | mMDDC | 5.17 ± 0.82 | 91.4 ± 3.12 | 92.57 ± 1.52 | 96.30 ± 0.75 | 80.97 ± 2.28 |
FL-AFP | imMDDC | 1.30 ± 0.60 | 47.73 ± 4.45 | 2.47 ± 0.43 | 38.50 ± 7.30 | 10.33 ± 2.68 |
 | mMDDC | 1.47 ± 0.57 | 53.70 ± 3.94** | 17.67 ± 2.35** | 65.57 ± 0.30** | 27.17 ± 3.94** |
D1-AFP | imMDDC | 2.40 ± 1.47 | 56.27 ± 2.50 | 3.50 ± 0.79 | 54.80 ± 11.47 | 12.30 ± 2.10 |
 | mMDDC | 1.87 ± 0.38 | 73.63 ± 4.76 | 65.47 ± 7.03 | 90.07 ± 3.66 | 59.27 ± 8.90 |
D2-AFP | imMDDC | 1.07 ± 0.17 | 44.30 ± 2.04 | 6.37 ± 1.09 | 63.53 ± 10.02 | 17.10 ± 3.65 |
 | mMDDC | 2.40 ± 0.40 | 41.57 ± 6.20** | 28.20 ± 4.59** | 87.63 ± 5.51 | 34.70 ± 3.43** |
D3-AFP | imMDDC | 1.90 ± 0.53 | 48.27 ± 2.28 | 6.90 ± 1.65 | 66.30 ± 9.89 | 21.97 ± 5.88 |
 | mMDDC | 2.07 ± 0.09 | 43.80 ± 6.91** | 27.47 ± 4.06** | 85.27 ± 4.89 | 39.27 ± 6.21** |